ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 177 filers reported holding ENANTA PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is 1.35 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,147 | +172.4% | 102,698 | +885.1% | 0.01% | +120.0% |
| Q1 2023 | $421 | -100.0% | 10,425 | -44.2% | 0.01% | -50.0% |
| Q3 2022 | $968,000 | +106.0% | 18,673 | +196.6% | 0.01% | +233.3% |
| Q4 2021 | $470,000 | +39.1% | 6,295 | +5.5% | 0.00% | +50.0% |
| Q3 2021 | $338,000 | -51.4% | 5,965 | -62.3% | 0.00% | -66.7% |
| Q2 2021 | $696,000 | +210.7% | 15,830 | +323.4% | 0.01% | -45.5% |
| Q3 2019 | $224,000 | – | 3,739 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 511,186 | $43,686,000 | 11.23% |
| GREAT POINT PARTNERS LLC | 210,400 | $17,981,000 | 2.80% |
| ARMISTICE CAPITAL, LLC | 456,000 | $38,970,000 | 2.34% |
| Matarin Capital Management, LLC | 210,208 | $17,964,376,000 | 1.16% |
| Sapphire Star Partners LP | 8,168 | $698,000 | 0.70% |
| Granahan Investment Management | 103,320 | $8,830,000 | 0.48% |
| FARALLON CAPITAL MANAGEMENT LLC | 867,500 | $74,137,000 | 0.44% |
| 361 CAPITAL LLC | 19,040 | $1,627,000 | 0.35% |
| ALGERT GLOBAL LLC | 17,922 | $1,532,000 | 0.33% |
| AlphaMark Advisors, LLC | 9,310 | $796,000 | 0.32% |